Wells Fargo’s Nutex Health NUTX Stock Holding History

Wells Fargo’s Portfolio NUTX Stock Details NUTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$201K	Sell	2,117 -2,617	-55%	-$321K	﹤0.01%	4699
2025 Q4	$779K	Buy	4,734 +2,076	+78%	+$275K	﹤0.01%	4152
2025 Q3	$275K	Sell	2,658 -242	-8%	-$23.7K	﹤0.01%	4736
2025 Q2	$361K	Buy	+2,900	New	+$375K	﹤0.01%	4378
2024 Q2	–	Sell	-21	Closed	-$307	–	7289
2024 Q1	$307	Buy	21 +4	+24%	+$80	﹤0.01%	6396
2023 Q4	$464	Buy	17 +1	+6%	+$31	﹤0.01%	6401
2023 Q3	$489	Buy	+16	New	+$772	﹤0.01%	6366
2023 Q2	–	Sell	-314	Closed	-$47.6K	–	7658
2023 Q1	$47.6K	Buy	+314	New	+$63.6K	﹤0.01%	5181
2022 Q4	–	Sell	-3	Closed	-$1K	–	7632
2022 Q3	$1K	Sell	3 -3	-50%	-$1.27K	﹤0.01%	6410
2022 Q2	$3K	Buy	+6	New	+$7.07K	﹤0.01%	6202

Other funds holding NUTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

TCM

Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Winmill & Co Rochester, New York $347M AUM 37.48% 1-Year Est. Return

Wells Fargo's NUTX Position: Q1 2026 in Review

Wells Fargo reduced its Nutex Health (NUTX) stake by 55% in Q1 2026, selling an estimated $321K and leaving 2,117 shares worth $201K. The position accounts for ﹤0.01% of the portfolio, ranked #4699.

Wells Fargo first reported a position in NUTX in Q2 2022 and has held it in 10 quarters since. The position peaked at $779K in Q4 2025. 129 funds tracked by Wall St. Rank hold NUTX as of Q1 2026.

Wells Fargo held 2,117 shares of Nutex Health worth $201K as of Q1 2026.
Wells Fargo sold 2,617 Nutex Health shares in Q1 2026, an estimated $321K.
Nutex Health made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #4699 holding.
Wells Fargo first reported a position in Nutex Health in Q2 2022 and has held it in 10 quarters since.
Wells Fargo's Nutex Health position peaked at $779K in Q4 2025.
129 funds tracked by Wall St. Rank held Nutex Health as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.